Lexicon Pharmaceuticals
LXRX
#6255
Rank
C$1.43 B
Marketcap
C$3.24
Share price
-1.28%
Change (1 day)
119.52%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): C-$0.09687

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is C-$0.09812. In 2025 the company made an earnings per share (EPS) of C-$0.20 an increase over its 2024 EPS that were of C-$0.90.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$0.09687-50.64%
2025C-$0.20-78.13%
2024C-$0.90-20%
2023C-$1.1231.15%
2022C-$0.86-0%
2021C-$0.8610.91%
2020C-$0.77-145.08%
2019C$1.71-206.09%
2018C-$1.61-5.74%
2017C-$1.71-10.95%
2016C-$1.922640%
2015C-$0.07009-96.34%
2014C-$1.91-2.53%
2013C-$1.96-9.09%
2012C-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
C$25.54-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.75-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$59.61-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
C-$8.56 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$10.99-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C-$0.02803-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
C-$1.05 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$1.96-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C-$2,294 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA